查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1649440

沙门氏菌检测与治疗市场 - 2025 年至 2030 年预测

Salmonella Testing and Treatment Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

沙门氏菌检测和治疗市场预计将以 6.28% 的复合年增长率成长，从 2025 年的 22.36 亿美元增长到 2030 年的 30.32 亿美元。

沙门氏菌是一种会引起食物中毒的细菌，可感染人类和动物。它感染多种动物并引起家禽、牛和猪的多种疾病。主要感染途径包括受污染的食物、水、交叉污染和表面，也可导致人类感染。沙门氏菌引起的常见疾病包括食物中毒、伤寒、沙门氏菌病、副伤寒、沙门氏菌脑膜炎和肺炎。确保食品安全对于防止沙门氏菌的传播至关重要。受污染的食物和饮料是沙门氏菌感染最常见的媒介。这就是为什么乳製品、加工食品、肉类和蛋类等食品在到达消费者手中之前必须经过严格的沙门氏菌检测。对牛肉和猪肉等肉类进行检测和诊断对于维护食品安全和防止沙门氏菌爆发至关重要。因此，沙门氏菌检测和治疗对于保护公众健康和确保安全消费至关重要。伤寒和副伤寒患者需要诊断测试和适当的治疗，这大大增加了沙门氏菌检测和治疗市场的需求。沙门氏菌爆发的不断增加导致食物中毒和伤寒等相关疾病的增加。这一趋势推动了对沙门氏菌诊断和治疗的需求，沙门氏菌不仅可以感染人类，还可以感染家禽等动物。沙门氏菌感染疾病数量的不断增加凸显了采取有效措施遏制病毒传播、确保公共卫生安全的必要性。针对此，世界各国政府正在实施更严格的法规，并投资于检测和治疗解决方案，进一步推动市场成长。此外，加强对食品安全的关注对于防止沙门氏菌爆发至关重要。检测和治疗诊断技术的进步也推动了市场的成长。

沙门氏菌检测和治疗市场驱动因素：

  • 有关沙门氏菌检测的政府法规趋势：全球范围内越来越多的政府法规要求食品製造商在将乳製品和加工食品等产品出售给消费者之前对其进行沙门氏菌检测。由于沙门氏菌疫情的增多，监管力度的加强促使各国政府在食品和饮料业实施更严格的预防措施。例如，美国食品药物管理局（FDA）为生产、加工、包装或保存人类食品的公司提供了指南，强调了沙门氏菌检测的重要性。这包括解释测试结果并在检测到污染时采取适当的措施。这些法规迫使食品製造商（包括家禽、肉类和牛肉产业）进行沙门氏菌检测，推动市场成长。

影响沙门氏菌检测和治疗市场的地理趋势：

  • 亚太地区是成长最快的地区：全球沙门氏菌检测和治疗市场分为北美、南美、欧洲、中东和非洲以及亚太地区等地区。预计预测期内北美将继续主导市场，而亚太地区预计将以最快的速度成长。

亚太地区的快速成长得益于中国、韩国和印度等新兴经济体加强其医疗保健基础设施。这一发展导致对沙门氏菌检测和治疗服务的需求增加。此外，这些国家不断加强的食品安全法规也进一步推动了市场的成长。食品加工设施的增加需要严格的食品安全标准，从而推动对有效的沙门氏菌检测解决方案的需求。此外，神经系统疾病的增加也推动了该地区对诊断的需求。另一方面，由于食源性疾病发生率高，加上法规结构严格且医疗保健行业强大，预计北美将占据市场主要份额。美国等国家的先进医疗基础设施支持有效的沙门氏菌治疗实践。总之，随着相关人员寻求有效的解决方案来对抗这种普遍的健康威胁，严格的政府法规和不断提高的食品安全意识等区域动态正在推动全球沙门氏菌检测和治疗市场的成长。

为什么要购买这份报告？

  • 深刻分析：获得深入的市场洞察，涵盖主要和新兴区域，重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他子区隔。
  • 竞争格局：了解全球主要企业所采用的策略策略，并了解正确策略带来的潜在市场渗透率。
  • 市场趋势和驱动因素：探索动态因素和关键市场趋势以及它们将如何影响市场的未来发展。
  • 可行的建议：利用洞察力做出策略决策，在动态环境中开闢新的业务流和收益。
  • 适合广泛用户：对于新兴企业、科学研究机构、顾问公司、中小企业和大型企业来说都是有益且具成本效益的。

它有什么用途？

产业与市场考量、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本支出决策、法律规范与影响、新产品开发、竞争影响

研究范围

  • 2022 年至 2030 年的历史资料与预测
  • 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
  • 竞争定位、策略和市场占有率分析
  • 收益成长和预测分析包括国家在内的细分市场和地区
  • 公司概况（尤其是主要趋势）

沙门氏菌检测和治疗市场细分如下：

按检验方法

  • 基于文化的方法
  • 基于分子的方法
  • 免疫检测

依治疗方法

  • 抗生素治疗
  • 支持治疗
  • 疫苗接种
  • 其他的

按最终用途

  • 食品工业
  • 卫生保健
  • 农业和畜牧业
  • 其他的

按地区

  • 北美洲
  • 美国
  • 加拿大
  • 墨西哥
  • 南美洲
  • 巴西
  • 阿根廷
  • 其他的
  • 欧洲
  • 英国
  • 德国
  • 法国
  • 西班牙
  • 其他的
  • 中东/非洲 沙乌地阿拉伯 阿根廷 其他中东/非洲
  • 沙乌地阿拉伯
  • UAE
  • 其他的
  • 亚太地区
  • 中国
  • 日本
  • 韩国
  • 澳洲
  • 印度
  • 印尼
  • 泰国
  • 其他的

目录

第 1 章 简介

  • 市场概况
  • 市场定义
  • 研究范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关利益者的主要利益

第二章调查方法

  • 研究设计
  • 研究过程

第三章执行摘要

  • 主要发现
  • CXO观点

第四章 市场动态

  • 市场驱动因素
  • 市场限制
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

5. 沙门氏菌检测与治疗市场（依检测方法划分）

  • 介绍
  • 基于文化的方法
  • 基于分子的方法
  • 免疫检测

6. 沙门氏菌检测与治疗市场（依治疗方法）

  • 介绍
  • 抗生素治疗
  • 支持治疗
  • 接种疫苗
  • 其他的

7. 沙门氏菌检测和治疗市场（依最终用途）

  • 介绍
  • 食品工业
  • 卫生保健
  • 农业和畜牧业
  • 其他的

8. 沙门氏菌检测与治疗市场（按地区）

  • 介绍
  • 北美洲
    • 按检验方法
    • 依治疗方法
    • 按最终用途
    • 按国家
  • 南美洲
    • 按检验方法
    • 依治疗方法
    • 按最终用途
    • 按国家
  • 欧洲
    • 按检验方法
    • 依治疗方法
    • 按最终用途
    • 按国家
  • 中东和非洲
    • 按检验方法
    • 依治疗方法
    • 按最终用途
    • 按国家
  • 亚太地区
    • 按检验方法
    • 依治疗方法
    • 按最终用途
    • 按国家

第九章竞争格局及分析

  • 主要企业和策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争仪錶板

第十章 公司简介

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Gold Standard Diagnostics
  • Romer Labs
  • BD
  • Pfizer Inc.
  • Agilent Technologies Inc.
  • Eurofins Scientific
  • QIAGEN
  • Bio-Rad Laboratories Inc.
简介目录
Product Code: KSI061617249

The salmonella testing and treatment market is expected to grow at a CAGR of 6.28%, reaching a market size of US$3.032 billion in 2030 from US$2.236 billion in 2025

Salmonella is a type of bacteria responsible for food poisoning and infections in both humans and animals. It can affect a wide range of animals, leading to various diseases in poultry, cattle, and pigs. The primary transmission routes include contaminated food, water, cross-contamination, and surfaces, which can also lead to human infections. Common illnesses caused by Salmonella include foodborne illnesses, typhoid fever, salmonellosis, paratyphoid fever, salmonella meningitis, and pneumonia.Ensuring food safety is crucial to preventing the spread of Salmonella. Contaminated foods and beverages are the most common transmission vectors for these bacteria. Therefore, rigorous salmonella testing is essential for food products such as dairy, processed foods, meats, and eggs before they reach consumers. Testing and diagnosing meats like beef and pork is vital for maintaining food safety and preventing outbreaks of salmonella. Consequently, salmonella testing and treatment are critical for protecting public health and ensuring safe consumption. Individuals affected by typhoid or paratyphoid require diagnostic testing and appropriate treatment, which significantly contributes to the demand within the salmonella testing and treatment market.The increasing incidence of salmonella outbreaks has led to a rise in related diseases among people, including foodborne illnesses and typhoid fever. This trend drives the demand for diagnosis and treatment not only in humans but also in animals such as poultry, which can also transmit the disease. The growing number of salmonella outbreaks emphasizes the need for effective measures to stop its spread and ensure public health safety. In response, governments are implementing stricter regulations and investing in testing and treatment solutions, further propelling market growth. Additionally, heightened focus on food safety is essential for preventing salmonella outbreaks. Advances in diagnostic techniques for testing and treatment are also significantly boosting market growth.

Drivers of the Salmonella Testing and Treatment Market:

  • Increasing Government Regulations for Salmonella Testing: There is a growing trend of government regulations worldwide mandating food manufacturers to conduct salmonella testing on their products-such as dairy items and processed foods-before they are sold to consumers. These regulations have tightened due to the rising number of salmonella outbreaks, prompting governments to enforce stricter preventive measures in the food and beverage sector. For example, the U.S. Food and Drug Administration (FDA) provides guidelines for companies involved in manufacturing, processing, packing, or holding human foods that emphasize the importance of salmonella testing. This includes interpreting test results and taking appropriate actions if contamination is detected. Such regulations compel food manufacturers-including those in poultry, meat, and beef sectors-to conduct salmonella testing, thereby driving market growth.

Geographical Trends Shaping the Salmonella Testing and Treatment Market:

  • Asia-Pacific as the Fastest-Growing Region: The global salmonella testing and treatment market is segmented into regions including North America, South America, Europe, the Middle East and Africa, and Asia Pacific. During the forecast period, Asia Pacific is expected to be the fastest-growing region while North America will continue to dominate the market.

The rapid growth in Asia Pacific is driven by emerging economies like China, South Korea, and India that are enhancing their healthcare infrastructure. This development increases the demand for salmonella testing and treatment services. Additionally, growing food safety regulations in these countries further accelerate market growth. The rise in food processing units necessitates stringent food safety standards and increases the need for effective salmonella testing solutions. Furthermore, an increase in neurological disorders is driving demand for diagnostics in this region.Meanwhile, North America is projected to maintain a significant share of the market due to high rates of foodborne illnesses coupled with strict regulatory frameworks and a robust healthcare sector. The advanced healthcare infrastructure in countries like the United States supports efficient salmonella treatment practices.In summary, both regional dynamics-such as stringent government regulations-and increasing awareness about food safety are driving growth in the global salmonella testing and treatment market as stakeholders seek effective solutions to combat this pervasive health threat.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

Salmonella Testing and Treatment Market has been segmented as following:

By Testing Method

  • Culture-based Methods
  • Molecular-based Methods
  • Immunoassay

By Treatment Method

  • Antibiotic Treatment
  • Supportive Care
  • Vaccination
  • Others

By End-User

  • Food Industry
  • Healthcare
  • Agriculture and Animal Husbandry
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • Australia
  • India
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. CXO Perspective

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. SALMONELLA TESTING AND TREATMENT MARKET BY TESTING METHOD

  • 5.1. Introduction
  • 5.2. Culture-based Methods
  • 5.3. Molecular-based Methods
  • 5.4. Immunoassay

6. SALMONELLA TESTING AND TREATMENT MARKET BY TREATMENT METHOD

  • 6.1. Introduction
  • 6.2. Antibiotic Treatment
  • 6.3. Supportive Care
  • 6.4. Vaccination
  • 6.5. Others

7. SALMONELLA TESTING AND TREATMENT MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Food Industry
  • 7.3. Healthcare
  • 7.4. Agriculture and Animal Husbandry
  • 7.5. Others

8. SALMONELLA TESTING AND TREATMENT MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Testing Method
    • 8.2.2. By Treatment Method
    • 8.2.3. By End-User
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Testing Method
    • 8.3.2. By Treatment Method
    • 8.3.3. By End-User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Testing Method
    • 8.4.2. By Treatment Method
    • 8.4.3. By End-User
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Spain
      • 8.4.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Testing Method
    • 8.5.2. By Treatment Method
    • 8.5.3. By End-User
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Testing Method
    • 8.6.2. By Treatment Method
    • 8.6.3. By End-User
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. Japan
      • 8.6.4.3. South Korea
      • 8.6.4.4. Australia
      • 8.6.4.5. India
      • 8.6.4.6. Indonesia
      • 8.6.4.7. Thailand
      • 8.6.4.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Thermo Fisher Scientific Inc.
  • 10.2. Merck KGaA
  • 10.3. Gold Standard Diagnostics
  • 10.4. Romer Labs
  • 10.5. BD
  • 10.6. Pfizer Inc.
  • 10.7. Agilent Technologies Inc.
  • 10.8. Eurofins Scientific
  • 10.9. QIAGEN
  • 10.10. Bio-Rad Laboratories Inc.